Harvard Health Letter

The shingles vaccine: Why hasn't it caught on?

The shingles vaccine Zostavax has not turned out to be as popular as was expected, due in part to its high cost and questions about its effectiveness.
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »